BridgeMD
A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]
EU CTIS ID: 2022-501426-38-00
What this study is testing
To evaluate if LY3819469 is superior to placebo in percent Lp(a) reduction
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participants must be at least 40 years old and have Lp(a) level ≥175 nmol/L at screening
- Participants if on lipid-lowering drugs or hormone therapy need to be on stable dose for at least 4 weeks prior to screening
- A body mass index within the range 18.5 to 40 kilogram/square meter
- Males who agree to use highly effective contraception methods or women not of childbearing age
You likely can't join if
- Have a history or presence of an underlying disease, or surgical, physical, medical, or psychiatric condition that in the opinion of the investigator, would affect participant safety within the study or interfere with participating in or completing the study or with the interpretation of data.
- Had major surgery within 3 months of day 1
- Had coronary, carotid, or peripheral arteria revascularization, stroke, heart attack or chest pain within 3 months of day 1
- Have uncontrolled diabetes
- Have uncontrolled high blood pressure
- Women of childbearing potential
The study team makes the final eligibility decision.
Where it's taking place
- China
- Japan
- Mexico
- United States
- Argentina
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include China; Japan; Mexico; United States; Argentina. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.